Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CENTURIA CAPITAL GROUP Capital/Financing Update 2017

Jun 28, 2017

64677_rns_2017-06-28_0cd9358f-3422-4a41-98ad-c28f1b97a553.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Centuria Capital Group (CNI), consisting of Centuria Capital Limited ABN 22 095 $|454>$ 336 (Company) and Centuria Funds Management Limited ACN 607 153 588 (Responsible Entity) as responsible entity of the Centuria Capital Fund ARSN 613 856 358 (Trust).

ABN

Company - ABN 22 095 454 336 Responsible entity - ACN 607 153 588 Trust - ARSN 613 856 358

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

+ Class of + securities issued or to
be issued
Fully paid ordinary stapled securities
Options over unissued shares; and
Options over unissued units (together the
Options)
$\overline{2}$ Number of + securities issued or
to be issued (if known) or
2,621,003 stapled securities
maximum number which may
be issued
20,098,470 options over unissued shares
20,098,470 options over unissued units

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid amount +securities, the outstanding and due dates for $^{\mathrm{+}}$ convertible payment; $if$ securities, the conversion price and dates for conversion)

$\overline{3}$

The stapled securities will be issued on the same terms as existing CNI stapled securities

The Options have the following terms:

  • Exercise price: \$1.30

  • Expiry date: 29 June 2022

4 Do the + securities rank equally
in all respects from the + issue
date with an existing + class of
quoted +securities?
Yes for the stapled securities.
If the additional *securities do
not rank equally, please state:
• the date from which they do
the extent to which they
for the
participate
next
dividend, (in the case of a
distribution)
trust,
or
interest payment
the extent to which they do
٠
not rank equally, other than
relation
in
to
the
next
dividend,
distribution
or
interest payment
- The Options will not be quoted on the
ASX.
- The Options may only be exercised by the
Option Holder after they have been issued
and prior to the Expiry Date.
- Each Option is for the issue of one Stapled
Security.
- At any time, the maximum number of
Options that the Option Holder may
exercise in any twelve month period is half
of the number of Options granted to the
Option Holder unless any person has voting
power (as defined in the Corporations Act)
of 15% or more in Centuria Capital Group, in
which case, the Option Holder may exercise
any number of unexercised Options that it
holds.
- The Stapled Securities issued pursuant to
the exercise of an Option will rank equally
with all other fully paid Stapled Securities
except that they will not be entitled to any
dividend or distribution if the record date
for determining entitlement to the dividend
and distribution was before the date of
issue.
- The Issuer will as soon as practicable after
issue and within the period specified in the
Listing Rules, apply for official quotation of
Stapled Securities issued upon exercise of
the Options.
- Any Option which has not been exercised
by the end of the Expiry Period will lapse.
- In the event of a reorganisation of the
issued capital of CNI, the Options will be
reorganised as required by the Listing Rules.
5 Issue price or consideration \$3,000,000 for the stapled securities.
The
Options
granted
for
were
nil
consideration.
6 Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
As described in the ASX Announcement
dated 29 June 2017.
6a Is the entity an + eligible entity
obtained
that has
security
holder approval under rule 7.1A?
If Yes, complete sections 6b - 6h
in relation to the + securities the
subject of this Appendix 3B, and
comply with section 6i
Yes
6b The date the security holder 29 November 2016
resolution under rule 7.1A was
passed
Number of + securities issued
without security holder approval
under rule 7.1
8,094,517
6d Number of + securities issued
with security holder approval
under rule 7.1A
14,624,956
6e Number of + securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
Nil
6f Number of + securities issued Nil
under an exception in rule 7.2
6g If + securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+ issue date and both values.
Include the source of the VWAP
calculation.
Yes
Issue date: 29 June 2017
CNI stapled security 15 day VWAP: \$1.20
Issue price: \$1.14 per stapled security (in
respect of the 2,621,003 stapled securities)
The exercise price of the Options is provided
above
  • $6h$ If +securities were issued under $\lceil$ rule $7.1A$ for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements
  • $6i$ Calculate the entity's remaining $\left[$ issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements
  • $\overline{7}$ +Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Number and +class of all $\bf 8$ *securities quoted on ASX (including the +securities in section 2 if applicable)

Number + Class
229, 815, 736 Fully paid stapled
securities

Number and +class of all 9 *securities not quoted on ASX (including the +securities in section 2 if applicable)

Number + Class
Four tranches of Performance Rights
Performance Rights issued pursuant to
were originally CNI's Executive
granted
to.
Incentive Plan.
executives.
The
number
of
Performance Rights
remaining are:
(i) Tranche
2:
1,390,927;
(ii) Tranche
3:
1,877,643; and
(iii) Tranche
4:
1,835,393.
$20,098,470$ options Options
over unissued shares
$20,098,470$ options
over unissued units

$N/A$

Please refer to Annexure 1

29 June 2017

Dividend policy (in the case of a 10 trust, distribution policy) on the increased capital (interests)

The 2,621,003 stapled securities are not entitled to any dividend or distribution if the record date for determining entitlement to the dividend and distribution was before the date of issue.

Part 2 - Pro rata issue

11 holder
approval
security
1 s
required?
N/A
12 Is the issue renounceable or non-
renounceable?
N/A
13 Ratio in which the + securities
will be offered
N/A
14 + Class of + securities to which the
offer relates
N/A
15 determine
date
+Record
to
entitlements
N/A
16 different
Will
holdings
on
registers (or subregisters) be
calculating
for
aggregated
entitlements?
N/A
17 Policy for deciding entitlements
in relation to fractions
N/A
18 Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
N/A
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 date for
receipt
of
Closing
acceptances or renunciations
N/A
20 Names of any underwriters N/A
21 Amount of any underwriting fee
or commission
N/A
22 Names of any brokers to the $N/A$
issue
  • Fee or commission payable to the $23$ broker to the issue
  • Amount of any handling fee $24$ payable to brokers who lodge acceptances or renunciations on behalf of security holders
  • If the issue is contingent on $25$ security holders' approval, the date of the meeting
  • $26$ Date entitlement and acceptance form and offer documents will be sent to persons entitled
  • If the entity has issued options, $27$ and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders
  • ${\bf 28}$ Date rights trading will begin (if $N/A$ applicable)
  • Date rights trading will end (if $N/A$ 29 applicable)
  • How do security holders sell 30 their entitlements in full through a broker?
  • How do security holders sell part | $31$ of their entitlements through a broker and accept for the balance?
  • How do security holders dispose | $32$ of their entitlements (except by sale through a broker)?
33 + Issue date

$N/A$

$N/A$

$N/A$

$N/A$

$N/A$

$N/A$

$N/A$

$N/A$

$N/A$

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

Type of +securities $34$ (tick one) *Securities described in Part 1 (Only in respect of the 2,621,003 stapled securities) $(a)$

All other +securities $(b)$

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

If the *securities are *equity securities, the names of the 20 largest holders of the 35 additional +securities, and the number and percentage of additional +securities held by those holders

If the *securities are *equity securities, a distribution schedule of the additional 36 *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ 5,001 - 10,000 10,001 - 100,000 100,001 and over

A copy of any trust deed for the additional +securities

Entities that have ticked box 34(b)

37

Number of +securities for which $N/A$ $38$ +quotation is sought

+Class of +securities for which 39 quotation is sought

$N/A$

40 Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

If the additional $^{\mathrm{*}}$ securities do not rank equally, please state:

  • the date from which they do $\bullet$
  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution $\alpha$ r interest payment

Reason for request for quotation 41 $N/A$ now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another *security, clearly identify that other 'security)

Number and +class of all 42 quoted on ASX +securities (including the +securities in clause $38)$

Number + Class
$\mid N/A$

Quotation agreement

  • +Quotation of our additional +securities is in ASX's absolute discretion. ASX $\mathbf{1}$ may quote the +securities on any conditions it decides.
  • We warrant the following to ASX. $\mathbf 2$
  • The issue of the *securities to be quoted complies with the law and is not for an illegal purpose.
  • There is no reason why those 'securities should not be granted *quotation.
N/A

An offer of the 'securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any 'securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the 'securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the $\bullet$ *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the 'securities be quoted.
  • We will indemnify ASX to the fullest extent permitted by law in respect of any $\overline{\mathbf{3}}$ claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any $\overline{4}$ information or document is not available now, we will give it to ASX before *quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

(Director/Company secretary)

Date: $29/6/17$

Sign here:

Print name:

JAMES LONIE

$== == == == ==$

Appendix 3B - Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid +ordinary
securities on issue 12 months before the
*issue date or date of agreement to issue
76,631,699
Add the following:
$\bullet$
Number of fully paid + ordinary securities
issued in that 12 month period under an
exception in rule 7.2
Number of fully paid +ordinary securities
$\bullet$
issued in that 12 month period with
shareholder approval
Number of partly paid +ordinary
$\bullet$
securities that became fully paid in that
12 month period
Note:
Include only ordinary securities here -
other classes of equity securities cannot
be added
- 77,194,733 stapled securities were issued
under the pro rata issue exception in rule 7.2
- 563,034 ordinary shares were issued in
respect of the vesting of performance rights
pursuant to CNI's executive incentive plan
- 50,209,882 stapled securities were issued
with the approval of securityholders
Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid +ordinary
securities cancelled during that 12 month
period
Nil
"А" 204,599,348
Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be changed]
Multiply "A" by 0.15 30,689,902
7.1 that has already been used Step 3: Calculate "C", the amount of placement capacity under rule
Insert number of + equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
30,689,902
Under an exception in rule 7.2
Under rule 7.1A
With security holder approval under rule
7.1 or rule 7.4
Note:
This applies to equity securities, unless
specifically excluded - not just ordinary
securities
Include here (if applicable) the securities
٠
the subject of the Appendix 3B to which
this form is annexed
It may be useful to set out issues of
٠
securities on different dates as separate
line items
"C" 30,689,902
placement capacity under rule 7.1 Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
"A" x 0.15 30,689,902
Note: number must be same as shown in
Step 2
Subtract "C" 30,689,902
Note: number must be same as shown in
Step 3
Total ["A" $\times$ 0.15] – "C" 0
[Note: this is the remaining placement
capacity under rule 7.1]

$\mathcal{L}^{\text{max}}_{\text{max}}$

$\label{eq:2.1} \frac{1}{\sqrt{2}}\int_{\mathbb{R}^3}\frac{1}{\sqrt{2}}\left(\frac{1}{\sqrt{2}}\right)^2\frac{1}{\sqrt{2}}\left(\frac{1}{\sqrt{2}}\right)^2\frac{1}{\sqrt{2}}\left(\frac{1}{\sqrt{2}}\right)^2\frac{1}{\sqrt{2}}\left(\frac{1}{\sqrt{2}}\right)^2.$

Part2

Rule 7.1A - Additional placement capacity for eligible entities Step 1: Calculate "A", the base figure from which the placement capacity is calculated $^{\alpha}$ A" 204,599,348 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of "A" $"D"$ $0.10$ Note: this value cannot be changed Multiply "A" by 0.10 20,459,934 Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used Insert number of +equity securities issued 14,624,956 or agreed to be issued in that 12 month period under rule 7.1A Notes: This applies to equity securities - not just ordinary securities Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items $``E"$ 14,624,956

+ See chapter 19 for defined terms.

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A

------- -- ---------------------------
"A" $\times$ 0.10 20,459,934
Note: number must be same as shown in
Step 2
Subtract "E" 14,624,956
Note: number must be same as shown in
Step 3
Total ["A" $\times$ 0.10] – "E" 5,834,978
Note: this is the remaining placement
capacity under rule 7.1A

$\bar{t}$